pharmaceutical · input
API for Bayer Aspirin, generic aspirin, and low-dose "baby aspirin" cardiovascular therapy. China produces >80% of global aspirin API; Shandong Xinhua Pharmaceutical alone accounts for the majority of global capacity.
3
Source countries
2
Companies
1
Goods affected
0
Claims on record
What depends on it
1 essential American goods rely on aspirin (acetylsalicylic acid) api somewhere upstream in their supply chain.
Who makes it
2 companies produce aspirin (acetylsalicylic acid) api.
World's largest aspirin API producer since the 1980s; 10,000+ tonnes/year aspirin capacity; exports ~5,000 tonnes/year to Pfizer, Bayer, Sanofi, GSK, Abbott, and Novartis. Also produces APAP and analgesics. Listed on Shanghai Stock Exchange.
French specialty pharmaceuticals company (HQ Ecully, Auvergne-Rhône-Alpes; private equity owned — EURAZEO); Seqens' Novacyl division in Roussillon, Isère, France is Europe's primary aspirin (acetylsalicylic acid) API producer and one of the few remaining non-Chinese aspirin API manufacturers globally. Novacyl was founded in 1928 (formerly Rhodia Pharma Solutions/Rhône-Poulenc); the Roussillon facility has been producing aspirin for nearly a century. Seqens also acquired PCAS (pharmaceutical chemistry specialty) and other French fine chemical companies to build a 'European pharmaceutical sovereignty' API platform — with significant French government encouragement post-COVID. Novacyl's aspirin production represents approximately 8-10% of global aspirin capacity — the primary European alternative to Chinese Shandong Xinhua for aspirin API procurement.
